Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thailand’s Universal Healthcare Plan Covers 95 Percent Of Population

This article was originally published in PharmAsia News

Executive Summary

Thailand has introduced universal healthcare in stages, and now covers more than 95 percent of its citizens, according to two recent reports on the early results of the Thai experience

You may also be interested in...



Thai Officials Say Compulsory Licenses Will Not Deter Biotech Business – BIO 2008 Exclusive

SAN DIEGO - Industry furor over Thailand's compulsory license position will not deter multinational companies from investing in the country, according to Thai officials who sat down with PharmAsia News during the BIO 2008 convention in San Diego

Thai FDA Head “Surprised” By Health Minister’s Decision To Remove Him From Post – PharmAsia News Interview

PERTH, Australia - One of the main architects of the previous Thai government's compulsory license policy, FDA head Siriwat Tiptaradol told PharmAsia News that he does not know why the country's Public Health Minister Chaiya Sasomsab removed him from his post

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071445

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel